Acumen Pharmaceuticals Presents in vitro Human Neuron Model for Evaluating Binding of Amyloid Beta Oligomers in Alzheimer's Disease

Data describe induced pluripotent stem cell -derived excitatory neurons as a human model for assessing selectivity of drug binding to soluble amyloid beta oligomers in Alzheimer’s diseaseResults... | March 28, 2023

Related Keywords

Sweden ,Gothenburg ,Vastra Gotalands Lan ,Erika Cline ,Drug Administration ,International Conference On Alzheimer ,Bioanalytical Methods At Acumen Pharmaceuticals ,Nasdaq ,Excitatory Neurons Assessed Usinga Panel ,Acumen Pharmaceuticals Inc ,Exchange Commission ,International Conference ,Bioanalytical Methods ,Soluble Amyloid Beta Oligomer Species ,Derived Excitatory Neurons Assessed Using ,Fast Track ,Acumen Pharmaceuticals ,Private Securities Litigation Reform Act ,Annual Report ,Nc Stock Exchange ,News ,Information ,Press Release ,Data ,Eescribe ,Induced ,Pluripotent ,Item ,Fell ,Excitatory ,Eurons ,Us ,Human ,Model ,Or ,Reassessing ,Selectivity ,F ,Drug ,Finding ,O ,Soluble ,Amyloid ,Meta ,Oligomers ,N Abos Us00509g2093 ,